chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Start of significant increase in multiple sclerosis exacerbations. Strong paresthesia every day multiple times a day, persistently since that date, continuing to the present. Always involving right arm, often involving right torso, sometimes involving right face or right leg. Previous exacerbations were often years apart and short lived. They have always been on right side of the body.  Neurologist recommended more aggressive treatment with Ocrevus (monoclonal antibody infusions).  New treatment not yet scheduled. Currently continuing with daily Glatopa injections.
(L) lateral arm - 10.8 x 7.5 cm erythematous area - with induration and warmth. Tender, no fluctuance - surrounding location of vaccination started 24 hrs after vaccination.
Information has been received from a medical assistant referring to a 23 year old patient of unknown gender. The patient's concurrent condition, medical history and concomitant therapy were unknown. On 22-SEP-2016, the patient was vaccinated with a dose of GARDASIL (dose, frequency and route were unknown, lot # L042837, expiration date:27-MAY-2017) for prophylaxis. On 13-FEB-2018, the patient received a dose of GARDASIL 9 (dose, frequency and route were unknown, N021571, expiration date:13-APR-2020) for prophylaxis. (interchange of vaccine products). No adverse effects reported.
Swollen lymph node under right arm. My entire arm was sore to my finger tip it felt as if my circulation was being cut off in my arm and it lasted about 48hrs. My under arm is still swollen and sore. I did have all the other side affects, fever, chills, dizzy, muscle aches and fatigue.
Patient was given a full dose (.5ml) of Moderna vaccine as a booster dose to follow their primary series of a J&J vaccine. Pt was not immunocompromised to healthcare provider's knowledge and should have received a half dose .25ml instead.
cold; running nose during the day; stuffy nose at night; This spontaneous case was reported by a consumer and describes the occurrence of NASOPHARYNGITIS (cold), RHINORRHOEA (running nose during the day) and NASAL CONGESTION (stuffy nose at night) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Mar-2021, the patient experienced NASOPHARYNGITIS (cold), RHINORRHOEA (running nose during the day) and NASAL CONGESTION (stuffy nose at night). At the time of the report, NASOPHARYNGITIS (cold), RHINORRHOEA (running nose during the day) and NASAL CONGESTION (stuffy nose at night) was resolving. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided by the reporter.   Treatment information was not provided.
Lethargic, body aches, headaches, nausea, continuing from Feb 9 to present date, 3/3/21
Same night of COVID-19 vaccine developed left armpit swelling and some tenderness about ~ 8 hours after vaccination.
11MAR aching swollen hands; 12MAr more swelling, rash, pain in knees, 13MAR fever 99.6 - 100.9 ;
On the afternoon of 7/15/2021, I was at work. I had been working at a computer, and when I stood up, it was if someone had flipped a cover over my left eye. I was able to see around the edges of my field of vision, but almost of it was blocked. I then went home and contacted my optometrist who made an appointment to see me the next day. When I saw Dr. on 7/16/2021, he performed a digital retinography procedure and determined that I had a central vein occlusion with hemorrhaging on the retina that resulted from it. Dr. then called my PCP to get her to see me immediately. Dr. instructed me to check my blood pressure regularly and keep a record of it to show my other Dr. I took my blood pressure about every 3 hours until I saw Dr. on 7/22/2021. At its highest, my blood pressure was 122/77. When I saw Dr. on 7/22/2021, she took 8 vials of blood for tests. The results of the tests were normal, except my cholesterol was 218 instead of 200, though Dr. said that that was no big deal. Dr. had me see him every 2 weeks for a couple of months and then once a month for about 2 or 3 months, so he could get retinography images and monitor the situation. Dr. says it is possible that I may regain my full vision in the left eye, though it would take at least a year. At the time of this writing, I am able to see out of my left eye for the most part, but there is a large, gray smudge in the upper left section of my field of vision. It's like a giant sunspot.
Information has been received from a physician concerning a 58 year old female who was vaccinated with a dose of zoster vaccine live (Oka/Merck).  It was reported that after vaccination the patient experienced soreness on the back of her hand, near the thumb.  The sore was reported as painful like zoster.  The patient also had a sore on the back of her hand by the pinky finger that was there previous to her receiving vaccine.  Unspecified medical attention was sought.  A product quality complaint was not involved.  Additional information has been requested. Follow up information was received from the physician concerning this 59 (previously reported as 58) year old white female with hypertension and type II diabetes mellitus who on an unspecified date was vaccinated with a dose of ZOSTAVAX. On 11-SEP-2007 the patient developed a rash on her face and left hand. The patient also had dysesthesia of the left hand, malaise and flushing. Medical attention was sought in the form of a doctor office visit. On 30-NOV-2007 the patient was considered recovered. No further information was provided. Additional information is not expected.
I woke up with bodily/head  aches and a strip thermometer indicates a positive reading for 102.5 Degrees fahrenheit.
pt vax w/1st dose hepatitis B on 12Apr90; c/o achiness in arms & swollen glands;c/o headcold a/vax. rec'd 2nd dose vax; no ADRl o.3rd dose sx recurrent w/inflam across shoulders, t100.8 & dyspnea;
1st shot last Sep (1yr); This case was reported by a consumer via interactive digital media and described the occurrence of incomplete course of vaccination in a patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (1st dose received in September 2021).   On an unknown date, the patient did not receive the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.    Additional Information: Additional Information: GSK Receipt Date: 22-SEP-2022 Reporter's Comments: This case was received from consumer via interactive digital media. The patient did not realize that Shingrix was a two dose shot. The patients first shot was in last September (1 year). The patient to know what you recommended. Additional Supportive Information: Till the time of reporting, the patient did not receive 2nd dose of Shingrix, which led to incomplete course of vaccination. The follow-up could not be possible as no contact details were available.
COVID-19; Vaccination site erythema/Arm got really red after the covid shot; Vaccination site swelling/Arm got really swollen after the covid shot; Vaccination site pain/Arm got really painful; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (COVID-19), VACCINATION SITE ERYTHEMA (Vaccination site erythema/Arm got really red after the covid shot), VACCINATION SITE SWELLING (Vaccination site swelling/Arm got really swollen after the covid shot) and VACCINATION SITE PAIN (Vaccination site pain/Arm got really painful) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product ADALIMUMAB (HUMIRA) for Hidradenitis suppurativa.    No Medical History information was reported.   In April 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In May 2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. In 2021, ADALIMUMAB (HUMIRA) (Subcutaneous) dosage was changed to at an unspecified dose and ADALIMUMAB (HUMIRA) (Subcutaneous) dosage was changed to at an unspecified dose. On an unknown date, the patient started ADALIMUMAB (HUMIRA) (Subcutaneous) at an unspecified dose. In January 2021, the patient experienced COVID-19 (COVID-19). In 2021, the patient experienced VACCINATION SITE ERYTHEMA (Vaccination site erythema/Arm got really red after the covid shot), VACCINATION SITE SWELLING (Vaccination site swelling/Arm got really swollen after the covid shot) and VACCINATION SITE PAIN (Vaccination site pain/Arm got really painful). In 2021, COVID-19 (COVID-19), VACCINATION SITE ERYTHEMA (Vaccination site erythema/Arm got really red after the covid shot), VACCINATION SITE SWELLING (Vaccination site swelling/Arm got really swollen after the covid shot) and VACCINATION SITE PAIN (Vaccination site pain/Arm got really painful) had resolved. Not provided          This case was identified as part of a retrospective clean-up activity where certain emails received in the Moderna mailbox were missed to be booked-in.  No concomitant medication was provided. No treatment medication was provided. It was unknown if patient was enrolled in a COVID-19 Vaccine Trial. Humrira daily dose was reported as Citrate free. It was reported that the Humira therapy stop date of APR-2021 and again patient started therapy with Humira on an unknown date of 2021 and stop date was MAY-2021. The reporter's causality of Humira for the events of arm got really red after the covid shot, arm got really swollen , after the covid shot, arm got really painful after the covid shot and COVID-19 was not provided.
THE PATIENT BROUGHT IN HER VACCINATION CARD AND THE FIRST DOSE WAS FILLED OUT ON 12/29/21 AND THE SEOND DOSE HAD ADMINISTRATION DATE OF 01/26/21 BUT WAS BLANK OTHERWISE. WE UNDERSTOOD PATIENT TO NEED BOOSTER DOSE OF 0.25 MLS AND PATIENT RECEIVED 0.25 MLS. WHEN WE GAVE VACCINE CARD BACK TO PATIENT SHE SAID THAT SHE NEVER RECEIVED SECOND DOSE. SO PATIENT SHOULD HAVE RECEIVED 0.5MLS AND RECIEVES BOOSTER DOSE OF 0.25 MLS. I HAVE FOLLOWED UP WITH OUR CLINICAL TEAM TO SEE WHAT STEPS SHOULD BE TAKEN FOR PATIENT AND WILL FOLLOW UP WITH PATIENT AFTER I RECEIVE GUIDANCE.
Early morning of April 15, 2021, I blacked out 3 times in the course of 20 minutes. I could not see before I blacked out the second time. I rested that night and the next day and seemed to recover.
aching in rt hip & down rt leg x 3 days w/ s/s worsening by 3rd day;NP @ clinic ordered flexiril which has helped being able to sleep @ noc, APAP during daytime hrs;
Felt warm, dizzy, nauseated, unable to swallow, bilat eyes itching, left arm (site of flu shot) itching.
Medical assistant called to report a T/E and reported that MMRII that experienced a temperature excursion was administered to one patient. No side effects or symptoms reported. No Additional AE/No PQC.  Names of vaccines involved (including lot/expir; No side effects or symptoms reported; This spontaneous report was received from a medical assistant referring to a patient of unknown age and gender. The patient's historical medications, medical history, concurrent conditions and concomitant medications were not reported.      On an unknown date, the patient was vaccinated with measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (rHA)(M-M-R II) lot number W019425, expiration date 07-JAN-2024 (dose, route of administration not reported) for prophylaxis (product storage error). No adverse event was provided.   The vaccine underwent a temperature excursion of 60.44 degrees Fahrenheit for 1 hour and 10 minutes. No previous excursions were detected.   The call was due to digital data logger.
About 12 hours after vaccination, awoke with mod-severe pain and swelling in multiple joints. Took ibuprofen, better not gone. Today, 3 days later, still with mild wrist synovitis (new for her, has OA but never this).
Headache started on crown of head and went from 0-100 in 30 seconds I was on my knees.
I had a sore arm after receiving the vaccine for about a day. I have a history of congestive heart failure since 2015. In 05/2023, I went to see my doctor as I noticed a change in my heartbeat. I felt very lightheaded. I wore a heart monitor, and I was diagnosed with a heart arrhythmia. I now take a higher dosage of metoprolol. I will follow-up with my doctor within the week.
This spontaneous report as received from a Registered Nurse refers to unspecified number of patients of unknown age and gender. On unknown dates, multiple patients were vaccinated with improperly stored (Oka/Merck) VARIVAX (dose, route and lot # not provided). No adverse events were reported. Additional information has been requested.
received three doses of GARDASIL 9 while she was HPV positive; No adverse effects; Information has been received from a physician via a field representative referring to a female adolescent of unknown age. Information about medical history and concomitant medication was unknown.       On unknown dates the patient was vaccinated with three doses of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast)(GARDASIL 9) (intramuscular; strength, dose, frequency, lot# and expiration date were unspecified) for prophylaxis, while she was human papillomavirus(HPV) positive(product use issue). No adverse effects were reported.
This case was reported by a pharmacist via Merck and described the occurrence of hepatitis B surface antigen positive in a 4-month-old female subject who was vaccinated with PEDIARIX (GlaxoSmithKline; unknown; unknown given on an unspecified. On 23 March 2013 the subject received 2nd dose of PEDIARIX (unknown). On an unspecified date in March 2013, at an unspecified time after vaccination with PEDIARIX, the subject experienced hepatitis B surface antigen positive. The infant subject was vaccinated with her 2nd dose of PEDIARIX on 23 March 2013 in the right thigh. A titer was drawn in March 2013, (the day of this report to Merck, specific date not specified) and the lab shows that the subject is hepatitis B surface antigen positive. At the time of reporting the outcome of the hepatitis B surface antigen positive was unspecified. Follow-up information was received on 24 April 2013 via healthcare professional who clarified concurrent vaccination PEDIARIX was administered intramuscularly in the left thigh given on 23 January 2013. On 23 March 2013 the subject received 2nd dose of PEDIARIX (.5 ml, intramuscular, right thigh). The healthcare professional reported that on 27 March 2013, 4 days after vaccination with PEDIARIX, the subject experienced hepatitis B surface antigen positive. The subject had a titer was drawn on 27 March 2013, on 28 March 2013 the Hepatitis B virus (HBV) DNA quantity polymerase chain reaction (PCR) was not detected. The reporting healthcare professional attributed the hepatitis B surface antigen positive to a false positive four days post vaccination. The immunization series with PEDIARIX was not delayed or discontinued. On 28 March 2013, the event was resolved.
pt was given 1st series of immun on 5MAY93; p/receiving immun in later AM pt began crying mom reported cry was different, very shrill & lasted @ least 2 1/2 hrs; pt was unconsolable @ this time;
18 hours after receiving the vaccine, passed out while walking in my house. No signs of dizziness or nausea preceded the episode. Lost consciousness for about 10 seconds, then was disoriented for about 2 minutes before being able to get up with assistance and move to my bed.
VAERS completed because of being Tested positive for COVID-19 infection 14 or more days after being fully vaccinated. 1st dose 12/21/20Lot#EK5730  2nd dose 01/11/21 lot#EL3248 Diagnosed covid positive:08/11/21 Symptom onset:08/10/21 Exposure:Travel Symptoms:Cough, fatigue,sore throat, runny nose,chills, headache.
the second knocked me off my butt; This case was reported by a consumer via interactive digital media and described the occurrence of feeling unwell in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Previously administered products included Covid 19 vaccine (1st dose received on an unknown date), Covid 19 vaccine (2nd dose received on an unknown date) and Shingles vaccine (1st dose received on an unknown date).   On an unknown date, the patient received the 2nd dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced feeling unwell. On an unknown date, the outcome of the feeling unwell was unknown.   It was unknown if the reporter considered the feeling unwell to be related to Shingles vaccine.  Additional details were provided as follows: The patient self-reported this case. The age at vaccination was not reported. The patient received dose of Shingles vaccine and felt knocked off his/her butt, like his/her second Covid 19 shot did. The follow-up would not possible as no contact details were available.
Patient admitted to hospital with COVID-19 virus infection; Cardiovascular disease; Dyspnea, unspecified type; SOB (shortness of breath). Still admitted.
This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a female patient of unknown age. No information was provided regarding concomitant medications, concurrent conditions or medical history. On or about late 2016, the patient was inoculated with ZOSTAVAX (lot number, dosage and route of administration not provided) for routine health maintenance and for the prevention of shingles. The vaccine did not prevent shingles, but rather caused the patient to contract a persistent strain of herpes zoster. Shortly after receiving the ZOSTAVAX, the patient developed a painful rash. The patient presented to a physician and was diagnosed as suffering from shingles. As a direct and proximate result of these malfunctions, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses and pain and suffering and other damages. The outcome of the events was unknown. Causality assessment was related. Additional information has been requested.
My father received his first Pfizer vaccine on 02/03/21. On 2/12/21 I rushed him to the ER. He was vomiting uncontrollably and had shortness of breath. Once arrived at ER, they immediately put him on oxygen. Vomiting lasted several hours. They tested him for Covid and did a chest x-ray. Tested positive for Covid. Chest x-ray showed Covid pneumonia. Was admitted. Stayed in hospital for 5 days and was then released to nursing home for physical and occupational therapy. He was very weak and on days experienced what they called Covid fog. After 2 weeks of therapy, he was released on 03/06/21 to go back home to his apartment, with extended visiting nurse therapy. On 3/10/21, was the first visiting nurse appointment. At 12:00 an RN came to his apartment from  Home Health Care. She checked his vitals. She said his blood pressure was good, lungs sounded good and oxygen level was 98. She said he was doing good and that she would not need to continue to come out and check on him weekly. She left. At 2:30 the same day, a Physical Therapist from Home Health Care came. She asked him lots of questions and adjusted my fathers' walker for him. He showed her how he was doing using the walker. Walked approximately 15-20 feet in his apartment. She checked his vitals before she left. His oxygen level was now at 91. She had him take a few deep breathes until his oxygen level was up to 93. She left and said she would be back on Friday the 12th to begin the actual physical therapy then. Within 10 minutes after she left my father started shaking uncontrollably and was having difficulties breathing. I called 911. Paramedics arrived. My fathers' oxygen level was all the way down to 74. They took him to the ER. When getting him out of ambulance he began vomiting. Vomiting lasted for hours just like when he went to the hospital back in February. They tried 3 different drugs to control the nausea. They did EKG, chest and abdomen scans. Was found that he had multiple blood clots and inflammation in his lungs and a bacterial infection in his blood. After testing, bacteria was found to be E Coli. Treated him with heparin for clots and antibiotics for infection and had him on oxygen in nose. Every day thereafter, he felt worse. They switched him to a high flow oxygen mask to keep his oxygen levels up. By Saturday night (early morning Sunday) on 03/14, they had taken the high flow oxygen mask off and hooked him up to a BiPap oxygen machine because his oxygen levels were dropping too low. We were then told by the lung doctor, that the damage to his lungs was extreme and that the next step would be to put him on a ventilator and feeding tube. My father did not want this per his will and his discussion with Dr earlier in the week. Dr indicated that he would not get better just being on the BiPap machine and we then chose to have them take him off of the machine because he did not want to go on life support. My father passed away on Sunday, March 14th around 6:30pm.
Initial symptoms, rapid heartrate (2 minutes of rapid heartrate happened one time) and a congested, stuffy nose (stuffiness was gone the next morning). That was the night of the vaccine. Also, my cycle started 10 days early with the 1st dose of the PFIZER vaccine and then I had another one 23 days later and then I had another one but it wasn't for 48 days. I usually have my cycle 28 days aside from pregnancy. I had a cycle 23rd of September and my next one started on the 10th of November. That is the one that is 48 days later. They tested to make sure my hormone levels were fine and everything came back normal.
Red itchy rash; Red itchy rash; This is a spontaneous report from a contactable consumer or other non hcp (patient). A 79-years-old female patient received BNT162B2 (Pfizer-Biontech Covid-19 Vaccine, Formulation: solution for injection, Batch/Lot Number EL9266, expiration date unspecified), via an unspecified route of administration, administered in Arm Left on 27Feb2021 as SINGLE DOSE for covid-19 immunization (79 year). Medical history included blood pressure measurement from an unknown date, blood cholesterol from an unknown date. Concomitant medication included valsartan (VALSARTAN) taken for blood pressure measurement from an unspecified start date and ongoing; simvastatin (SIMVASTATIN) taken for blood cholesterol from an unspecified start date and ongoing. On 01MAR2021, the patient developed red itchy rash and red itchy erythematous. Therapeutic measures were taken as a result of the events and patient was treated with an over-the-counter lotion for itchiness. The outcome of the events was reported as not recovered.  No follow-up attempts are possible. No further information is expected.